INNOVATION PHARMACEUTICALS INC | 8-K: Current report
INNOVATION PHARMACEUTICALS INC | 8-K: Current report
INNOVATION PHARMACEUTICALS INC | 10-Q: Q1 2024 Earnings Report
INNOVATION PHARMACEUTICALS INC | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
INNOVATION PHARMACEUTICALS INC | 8-K: Current report
INNOVATION PHARMACEUTICALS INC | 10-K: FY2023 Annual Report
INNOVATION PHARMACEUTICALS INC | 10-Q: Q3 2023 Earnings Report
INNOVATION PHARMACEUTICALS INC | 10-Q: Q2 2023 Earnings Report
INNOVATION PHARMACEUTICALS INC | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
INNOVATION PHARMACEUTICALS INC | 8-K: Current report
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 10-Q: Q1 2023 Earnings Report
INNOVATION PHARMACEUTICALS INC | 10-K: FY2022 Annual Report
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kips Bay Select LP(9.92%)
INNOVATION PHARMACEUTICALS INC | 8-K: Current report
INNOVATION PHARMACEUTICALS INC | 10-Q: Q3 2022 Earnings Report
Unlock the Full List